
-
MLB Nationals fire manager Martinez, GM Rizzo after loss
-
US tariffs to kick in Aug 1, barring trade deals
-
Trump slams former ally Musk's political party as 'ridiculous'
-
Three things we learned from the second England-India Test
-
Norway reach Euro 2025 quarter-finals as Swiss down eliminated Iceland
-
Alcaraz vows to avoid Murray after defeat on golf course
-
Alcaraz finds magic touch at Wimbledon as Sabalenka storms into quarter-finals
-
Run-hungry Gill glad to 'lead by example' as India level England series
-
Rockets confirm arrival of Durant in unprecedented NBA seven-team trade
-
Alcaraz survives Rublev test to stay on course for Wimbledon hat-trick
-
New Zealand's Dixon wins seventh IndyCar Mid-Ohio title
-
US tariffs to kick in Aug 1, barring trade deals: Bessent
-
England consider Archer and Atkinson recall after heavy India defeat
-
Durant deal becomes NBA-record seven-team trade: reports
-
Verstappen laments 'really difficult' Silverstone fifth
-
BRICS nations hit out at Trump tariffs
-
Hansen shoots Norway to brink of Euro 2025 quarter-finals
-
Jennifer Geerlings-Simons becomes Suriname's first woman president
-
Netanyahu says Trump meeting could 'advance' Gaza deal ahead of Doha talks
-
BRICS meeting in Rio hits out at Trump tariffs
-
Hulkenberg shakes off F1's longest unwanted record with podium finish at Silverstone
-
US tariffs to kick in Aug 1 barring trade deals: Treasury Secretary
-
Norris in dream land after epic home win at Silverstone
-
Sabalenka storms into Wimbledon quarters as Alcaraz braces for Rublev test
-
Sabalenka downs former doubles partner to power into Wimbledon quarters
-
'Jurassic World: Rebirth' roars to top of N.American box office
-
Wimbledon's underdogs enjoy their week in the sun
-
Deep strikes as India hammer England in second Test
-
Sabalenka powers into Wimbledon quarter-finals
-
Dutch powerhouse Van der Poel takes Tour de France lead
-
Emotional Norris wins epic rain-hit British Grand Prix
-
Australian pacemen rattle West Indies run chase
-
Syria fights 'catastrophic' fires for fourth day
-
'Stole the game': Wimbledon line-calling tech malfunctions
-
Van der Poel powers into Tour de France lead
-
Norris wins home British Grand Prix
-
Wimbledon line-calling tech malfunctions
-
BRICS gather in Rio as Trump tariff wars loom
-
Bayern's Musiala out for 'long period' with broken fibula
-
Deep leaves England on brink of defeat as India eye series-levelling win
-
Caldentey's Arsenal stint boosting her bid for Euros and Ballon d'Or glory
-
Fritz into Wimbledon quarter-finals after Thompson retires
-
Armed gang attacks Kenya Human Rights Commission on eve of protests
-
Hezbollah chief says won't surrender under Israeli threats
-
Arsenal sign Spain midfielder Zubimendi
-
India resume quest to level England series after rain delay
-
Arsenal sign midfielder Zubimendi from Real Sociedad
-
Alcaraz seeks top gear at Wimbledon as Sabalenka stays calm
-
'Emergency' at Afghan border as migrant returns from Iran surge ahead of deadline
-
Rain delays India's bid for win over England in second Test

Japan biochemist who discovered statins, Akira Endo, dies
Japanese biochemist Akira Endo, who discovered cholesterol-lowering statins, has died aged 90, his former student and colleague said on Tuesday.
Statins, which can prevent heart attacks or strokes, are among the most commonly prescribed drugs worldwide.
Keiji Hasumi, a professor who was a long-time associate of Endo, said the scientist had died on June 5.
"His work was truly great. Statins didn't exist before Endo," Hasumi told AFP. "It has the same value and impact as the discovery of penicillin."
Johns Hopkins Medicine says more than 200 million people take statins. Studies say the global market for them was worth $15 billion in 2023 and is expected to grow.
Endo experimented on thousands of microbes to reach his 1973 discovery of mevastatin -- an agent derived from penicillin that reduces so-called "bad" cholesterol in the blood.
The researcher "was a tough, strict person. He was insightful and perceptive," and "able to see the hidden essence of things", Hasumi said.
Endo was born in 1933 to a farming family in rural northern Japan.
His ambitions began early thanks to his grandfather, who was interested in medicine and became a "great home teacher", Endo said in a 2008 autobiographical essay.
As a student, Endo became interested in antibiotics like penicillin, "deeply impressed" by how many lives they had saved, his essay in the journal Nature Medicine said.
Endo carried out research in New York in the late 1960s, when coronary heart disease was the main cause of US deaths.
"I often saw ambulances coming to take elderly people who had suffered a heart attack to hospital", which "made me realise the importance of developing a cholesterol-lowering drug", he said.
Endo worked at the Tokyo University of Agriculture and Technology, which issued a statement expressing condolences over his death, and at Japanese drugmaker Sankyo, now a part of Daiichi-Sankyo.
He spent two years testing 6,000 strains of microbe in the search for a new drug that could help achieve his goal before finally finding mevastatin.
Conflicting reports on the benefits and potential harms of statins in recent years have prompted some people prescribed the drugs to stop taking them.
"Are statins safe? For most people, the answer is a resounding yes, according to a 2014 Johns Hopkins meta-analysis of 20 years worth of published research," the US university says.
Endo was a strong candidate for a Nobel Prize, but never won. In a report on his death, Japanese broadcaster NHK noted Endo had received other accolades, including being honoured as a Person of Cultural Merit by the government in 2011.
His discovery "was the result of many twists and turns", Hasumi said.
"He reached his goal by overcoming so many challenges, without which medicines cannot be created, I think I remember him saying."
Y.Kobayashi--AMWN